DuoStim reduces time to pregnancy, minimizes treatment discontinuation, and is potentially cost-effective
- PMID: 37352226
- DOI: 10.1093/humrep/dead113
DuoStim reduces time to pregnancy, minimizes treatment discontinuation, and is potentially cost-effective
Comment in
-
Reply: The discussion surrounding DuoStim is resolved.Hum Reprod. 2023 Aug 1;38(8):1644-1645. doi: 10.1093/humrep/dead114. Hum Reprod. 2023. PMID: 37352217 No abstract available.
Comment on
-
Routine double-ovarian-stimulation (DuoStim) in poor responders lacks rationale, evidence, and follow-up.Hum Reprod. 2023 Mar 1;38(3):329-333. doi: 10.1093/humrep/dead002. Hum Reprod. 2023. PMID: 36692185
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
